8 天on MSN
Photodynamic therapy technique deactivates tumors from within, using clinically approved agents
Researchers at the Madrid Institute for Advanced Studies in Nanoscience (IMDEA Nanociencia) and the National Center for ...
AZoNano on MSN
Nanomaterials 2026: Innovations and Future Perspectives
Over the course of three days, we will explore a wide range of topics, including “Nanomedicine & Bionanotechnology”, “ Nanomaterials in catalysis”, “Nanophotonic, Nanoelectronics, Nanosensors and ...
Sana Biotechnology, Inc. surged after hedge fund manager Eric Jackson called it a potential "100-bagger" due to its pioneering diabetes cell therapy. Sana Biotechnology's breakthrough islet cell ...
Purple Biotech (PPBT) stock underwent a massive rally on Wednesday after the clinical-stage company announced a production milestone for IM1240. This is a tri-specific antibody from the company’s ...
HIGHLAND PARK Fla. — A Florida nonprofit is on a mission to revive the state’s farmland with sustainability in mind. Biotech Applied Research is turning waste into “biochar,” a charcoal-like material.
Veterans of the biotech business sometimes talk about surviving various “winters” for their industry — periods when funding drops and companies cut jobs or shut down entirely. They’re living through a ...
New York Times bestselling author Mary Roach encouraged the use of humor to break down barriers in graphic and taboo medical discourse while promoting her new book “Replaceable You: Adventures in ...
After years of disappointments, biotech stocks are on an unaccustomed run. The SPDR S&P Biotech ETF, which trades under the ticker XBI, is up around 20% since the start of September, and is ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
Shares of Praxis Precision Medicine shot 251% higher in a little over a week during the month of October. Praxis Precision Medicine announced successful results from a phase 3 trial with its lead ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果